Navigating China’s Agrochemical Trends: Key Takeaways for U.S. Ag Retailers from David Li’s China Price Index

As U.S. ag retailers look toward the 2025/2026 purchasing season, staying informed about China’s agrochemical market is critical. David Li, a respected voice at CropLife’s sister brand, AgriBusiness Global, provides a detailed breakdown in his most recent China Price Index that should serve as a strategic guide for procurement and risk management. With volatility in pricing, tightening supply chains, and regulatory shifts, Li offers a clear warning: understanding timing, cost structures, and quality dynamics is more essential than ever.

Glyphosate Rebounding: A Cautious Window for Buyers

Glyphosate prices in China have bottomed out and are now in a moderate rebound, driven largely by reduced inventory and a shift in buying patterns from Brazil, where buyers are placing larger, upfront orders.

“Glyphosate prices are expected to remain in a stable price pullback until August,” Li writes. “Purchasing decisions are almost impossible to make at price bottom, and more realistically, buying behavior occurs before or after price turning points.”

For U.S. retailers, this suggests a narrow window of opportunity to lock in stable prices before year-end. Holding off too long could mean buying into higher prices in Q4 or early 2026.

Glufosinate Struggles: A Complex Picture for Resistance Management

Despite being positioned as a potential glyphosate alternative, glufosinate remains in oversupply, with sluggish overseas demand and price competition driving down margins.

“The continuous low price of glufosinate cannot be exchanged for an increase in sales volume,” says Li. “Various factors affecting demand are becoming more complex.”

Retailers should be cautious about banking on glufosinate as a volume play. Even with low prices, demand is not responding, especially as co-formulated AIs like clethodim rise in cost — hurting overall formulation affordability.

Furthermore, regulatory changes are coming. China is preparing to introduce a chloride content standard for glufosinate formulations. This means higher compliance costs, but also likely improved formulation quality.

“The quality of China’s glufosinate formulations will further develop toward standardization and high quality,” notes Li. “The price of Chinese glufosinate formulations will also have a certain degree of upward space.”

Paraquat and Diquat: Stockpiling Strategy Could Be Critical

Paraquat remains under high production cost pressure. Supply tightness—especially from pyridine feedstock constraints—means that August 2025 may be the best time for U.S. retailers to stock up.

“China’s paraquat AI EXW price may return to 2.5 USD/kg by end of 2025,” Li forecasts.

With North American winter demand aligning with China’s seasonal stockpiling, paraquat prices could spike again by Q4. Buying now avoids this clash in demand cycles.

Diquat, on the other hand, has seen prices stabilize after South America’s season ends. Retailers should monitor diquat as a potential value-buy in the coming months.

Fungicide Forecasts: Firming for Mancozeb, Weakening for Prothioconazole

Mancozeb prices are firming due to strong South American demand and low spot supply in China. South American buyers are moving to long-term contracts, potentially tightening the spot market further for U.S. buyers later this year.

In contrast, prothioconazole is expected to continue downward in price, thanks to increasing Chinese production capacity.

“Prothioconazole may still have room for downward movement,” Li writes.

This could present an opportunity for budget-conscious procurement, especially if combined with better logistics planning to secure volumes before the 2026 season.

Insecticides and Intermediate Trends: More Costs, More Scrutiny

Abamectin prices are climbing due to tight production scheduling. Meanwhile, chlorantraniliprole (CTPR) faces indirect supply pressure after an explosion at Youdao Chemical. The real bottleneck is upstream K amine intermediates, which are hazardous to produce and limited in output.

“The shortage… may continue to support the price of CTPR in China,” says Li.

Retailers relying heavily on CTPR or pyrethroids should expect ongoing pricing volatility and consider locking in early Q4 volumes to avoid winter storage-related spikes.

Bigger Picture: China’s Industry Shifting Toward Quality and IP Protection

While pricing is the headline, Li emphasizes a deeper transformation in China’s agrochemical industry. Regulatory enforcement is tightening, IP protection is improving, and formulation standards are being raised—especially as exports of finished products from China increase.

“Low price is not a sufficient condition for tier one suppliers,” Li argues. “Breakthroughs in high-value markets and more services are enabling Chinese pesticide enterprises… to break out of the trap of low-priced red sea competition.”

Retailers should increasingly evaluate supplier transparency, formulation quality, and regulatory compliance when sourcing Chinese products — not just price.

Final Takeaway: Strategic Timing and Diversified Risk Management

The dual forces of supply volatility and regulatory evolution in China are making it harder to rely solely on historical price cycles. U.S. ag retailers will need to:

• Monitor short-term price signals—especially for paraquat, glyphosate, and CTPR.
• Plan mid-term buys strategically, before winter demand and Chinese stockpiling coincide.
• Demand transparency and quality assurance from Chinese suppliers.
• Stay flexible in product selection as glufosinate and clethodim markets remain unpredictable.

As David Li concludes, understanding true price turning points and the underlying supply dynamics is what separates strategic buyers from reactive ones. In 2025, that understanding may make all the difference.